EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity modulation

Israel Ríos, Cristina Herrero, Mónica Torres-Torresano, Baltasar López-Navarro iD, María Teresa Schiaffino, Francisco Díaz Crespo, Alicia Nieto-Valle, Rafael Samaniego, Yolanda Sierra-Palomares, Eduardo Oliver iD, Fernando Revuelta-Salgado, Ricardo García-Luján und 4 weitere

eLife · 2025

DOI: 10.7554/elife.102659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Israel Ríos und 15 weiteren Autor:innen. Beteiligte Einrichtung: Myeloid Cell Laboratory, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Granulocyte-Macrophage Colony-Stimulating Factor, Glycogen Synthase Kinase 3, Cellular Reprogramming. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Comunidad de Madrid, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monocyte-derived macrophages recruited into inflamed tissues can acquire an array of functional states depending on the extracellular environment. Since the anti-inflammatory/pro-fibrotic macrophage profile is determined by MAFB, whose activity/protein levels are regulated by GSK3, we addressed the macrophage reprogramming potential of GSK3 modulation. GM-CSF-dependent (GM-MØ) and M-CSF-dependent monocyte-derived macrophages (M-MØ) exhibited distinct levels of inactive GSK3, and inhibiting GSK3 in GM-MØ led to the acquisition of transcriptional, phenotypic, and functional properties characteristic of M-MØ (enhanced expression of IL-10 and monocyte-recruiting factors, and higher efferocytosis). These reprogramming effects were also observed upon GSK3α/β knockdown and through GSK3 inhibition in ex vivo isolated human alveolar macrophages (AMØ). Notably, GSK3 downmodulation potentiated the transcriptional signature of interstitial macrophages (IMØ) while suppressing the AMØ-specific gene profile. Indeed, heightened levels of inactive GSK3 and MAFB-dependent proteins were observed in severe COVID-19 patients’ lung macrophages, highlighting the GSK3-MAFB axis as a therapeutic target for macrophage reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophages, AlveolarGranulocyte-Macrophage Colony-Stimulating FactorGlycogen Synthase Kinase 3Cellular ReprogrammingHumansMafB Transcription FactorCOVID-19Glycogen Synthase Kinase 3 betaSARS-CoV-2Macrophage Colony-Stimulating Factor

Stichwörter der Autor:innen

GSK3humanimmunologyinflammationmacrophage reprogrammingmacrophages

Substanzen

Granulocyte-Macrophage Colony-Stimulating FactorGlycogen Synthase Kinase 3MafB Transcription FactorGlycogen Synthase Kinase 3 betaMacrophage Colony-Stimulating Factor

Autor:innen und Institutionen

  • Myeloid Cell Laboratory, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
  • Laboratorio de Inmuno-Metabolismo e Inflamación, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Servicio de Anatomía Patológica, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Unidad de Microscopía Confocal, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Experimental Pharmacology and New Tragets in Cardiopulmonary Disorders, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
  • Servicio de Neumología. Hospital Universitario de Octubre, Madrid, Spain.

ORCID-Profile: Baltasar López-Navarro, Eduardo Oliver, Amaya Puig-Kröger, Angel L Corbí

Förderung

  • Ministerio de Ciencia e Innovación
  • Comunidad de Madrid
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia, Innovación y Universidades
  • European Commission - NextGenerationEU
  • CSIC Talent Attraction program
  • European Commission – NextGenerationEU

Zitieren

APA

Ríos, I., Herrero, C., Torres-Torresano, M., López-Navarro, B., Schiaffino, M. T., Díaz Crespo, F., Nieto-Valle, A., Samaniego, R., Sierra-Palomares, Y., Oliver, E., Revuelta-Salgado, F., García-Luján, R., Sánchez-Mateos, P., Delgado, R., Puig-Kröger, A., & Corbí, A. L. (2025). Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity modulation. eLife. https://doi.org/10.7554/elife.102659

Vancouver

Ríos I, Herrero C, Torres-Torresano M, López-Navarro B, Schiaffino MT, Díaz Crespo F, et al. Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity modulation. eLife. 2025. doi:10.7554/elife.102659

BibTeX
@article{Ros2025,
  author = {Ríos, Israel and Herrero, Cristina and Torres-Torresano, Mónica and López-Navarro, Baltasar and Schiaffino, María Teresa and Díaz Crespo, Francisco and Nieto-Valle, Alicia and Samaniego, Rafael and Sierra-Palomares, Yolanda and Oliver, Eduardo and Revuelta-Salgado, Fernando and García-Luján, Ricardo and Sánchez-Mateos, Paloma and Delgado, Rafael and Puig-Kröger, Amaya and Corbí, Angel L},
  title = {Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity modulation},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.102659}
}
Kostenlos starten →